Abstract

Background:Patients undergoing oncological treatment may experience a variety of symptoms that interfere with their ability to eat and enjoy meals. This compromises their nutritional status and impairs quality of life (QOL).Objective:Compare a home-delivered protein-rich service as a therapeutic measure to patients undergoing chemotherapy with usual care.Methods:Randomized clinical trial enrolling patients (n = 148) receiving chemotherapy. The intervention group received 6 protein-rich dishes per day for 3 weeks, the control group maintained their usual diet. QOL, energy and protein intake, nutritional and functional status, physical performance, symptom burden, and caregiver QOL were assessed.Results:No difference in QOL was found between the groups but QOL in the gastrointestinal and gynecological tumor groups increased by 8.4 points (95% confidence interval [CI] 1.0-15.8;P< .05) after the intervention, while scores in other tumor groups did not change. Significant effects were observed in energy intake (21%; 95% CI 10.4-32.1) and Short Physical Performance Battery (0.28; 95% CI 0.2-0.8) in the intervention group.Conclusions:In patients with cancer undergoing chemotherapy, a home-delivered protein-rich meal service did not improve QOL for the total group but QOL significantly improved in the subpopulation with abdominal cancer.Implications for Practice:Future research should focus on vulnerable patients with a high risk for malnutrition and symptoms, such as gastrointestinal and gynecological malignancies, considering the beneficial results in this subgroup.Foundational:A home-delivered protein-rich meal service is feasible in patients with cancer while undergoing chemotherapy. QOL increased in gastrointestinal and gynecological cancer patients receiving this meal service.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call